Control of Bovine Mastitis: Old and Recent Therapeutic Approaches

详细信息    查看全文

• 作者：Fernanda Gomes ; Mariana Henriques
• 刊名：Current Microbiology
• 出版年：2016
• 出版时间：April 2016
• 年：2016
• 卷：72
• 期：4
• 页码：377-382
• 全文大小：362 KB
• 参考文献：1.Alluwaimi AM (2004) The cytokines of bovine mammary gland: prospects for diagnosis and therapy. Res Vet Sci 77(3):211–222CrossRef PubMed
  2.Atulya M, Mathew AJ, Rao JV, Rao CM (2014) Influence of milk components in establishing biofilm mediated bacterial mastitis infections in cattle: a fractional factorial approach. Res Vet Sci 96:25–27CrossRef PubMed
  3.Bannerman DD, Wall RJ (2005) A novel strategy for the prevention of Staphylococcus aureus-induced mastitis in dairy cows. Information Systems for Biotechnology (isb) news report, 1–4
  4.Basdew IH, Laing MD (2011) Mini-review: biological control of bovine mastitis using bacteriophage therapy. In: Méndez-Vilas A (ed) Science against microbial pathogens: communicating current research and technological advances. World Scientific, Singapore, pp 386–393
  5.Basdew IH, Laing MD (2014) Stress sensitivity assays of bacteriophages associated with Staphylococcus aureus, causal organism of bovine mastitis. Afr J Microbiol Res 8(2):200–210CrossRef
  6.Baskaran SA, Kazmer GW, Hinckley L, Andrew SM, Venkitanarayanan K (2009) Antibacterial effect of plant-derived antimicrobials on major bacterial mastitis pathogens in vitro. J Dairy Sci 92(4):1423–1429CrossRef
  7.Berni E, Marcato PD, Nakazato G, Kobayashi RKT, Vacchi FI, Umbuzeiro GA, Durán N (2013) Violacein/poly(ε-caprolactone)/chitosan nanoparticles against bovine mastistis: Antibacterial and ecotoxicity evaluation. J Phys 429:012030
  8.Bogni C, Odierno L, Raspanti C, Giraudo J, Larriestra A, Reinoso E, Lasagno M, Ferrari M, Ducrós E, Frigerio C, Bettera S, Pellegrino M, Frola I, Dieser S, Vissio C (2011) War against mastitis: current concepts on controlling bovine mastitis Pathogens. In: Méndez-Vilas A (ed) Science against microbial pathogens: communicating current research and technological advances. World Scientific, Singapore, pp 483–494
  9.Bouchard DS, Rault L, Berkova N, Le Loir Y, Even S (2013) Inhibition of Staphylococcus aureus invasion into bovine mammary epithelial cells by contact with live Lactobacillus casei. Appl Environ Microbiol 79(3):877–885PubMedCentral CrossRef PubMed
  10.Cardozo VF, Lancheros CA, Narciso AM, Valereto EC, Kobayashi RK, Seabra AB, Nakazato G (2014) Evaluation of antibacterial activity of nitric oxide-releasing polymeric particles against Staphylococcus aureus and Escherichia coli from bovine mastitis. Int J Pharm 473(1–2):20–29CrossRef PubMed
  11.Chibani-Chennoufi S, Dillmann ML, Marvin-Guy L, Rami-Shojaei S, Brüssow H (2004) Lactobacillus plantarum bacteriophage LP65: a new member of the SPO1-like genus of the family Myoviridae. J Bacteriol 186:7069–7083PubMedCentral CrossRef PubMed
  12.Crist WL, Harmon RJ, O’Leary J, McAllister AJ (1997) Mastitis and its control [online]
  13.Dehkordi SH, Hosseinpour F, Kahrizangi AE (2011) An in vitro evaluation of antibacterial effect of silver nanoparticles on Staphylococcus aureus isolated from bovine subclinical mastitis. Afr J Biotechnol 10(52):10795–10797
  14.DeGraves FJ, Fetrow J (1991) Partial budget analysis of vaccinating dairy cattle against coliform mastitis with an Escherichia coli J5 vaccine. J Am Med Assoc 199:451
  15.Dias RS, Eller MR, Duarte VS, Pereira ÂL, Silva CC, Mantovani HC, Oliveira LL, Silva Ede A, De Paula SO (2013) Use of phages against antibiotic-resistant Staphylococcus aureus isolated from bovine mastitis. J Anim Sci 91(8):3930–3939CrossRef PubMed
  16.Domadia P, Swarup S, Bhunia A, Sivaraman J, Dasgupta D (2007) Inhibition of bacterial cell division protein FtsZ by cinnamaldehyde. Biochem Pharmacol 74:831–840CrossRef PubMed
  17.Doss A, Mubarack HM, Vijayasanthi M, Venkataswamy R (2012) In vitro antibacterial activity of certain wild medicinal plants against bovine mastitis isolated contagious pathogens. Asian J Pharm Clin Res 5(2):90–93
  18.Fenton M, Keary R, McAuliffe O, Ross RP, O’Mahony J, Coffey A (2013) Bacteriophage-derived peptidase CHAPK eliminates and prevents staphylococcal biofilms. Int J Microbiol 2013:625341PubMedCentral CrossRef PubMed
  19.Fonseca AP, Estrela FT, Moraes TS, Carneiro LJ, Bastos JK, Santos RA, Ambrósio SR, Martins CHG, Veneziani RCS (2013) In vitro antimicrobial activity of plant-derived diterpenes against bovine mastitis bacteria. Molecules 18:7865–7872CrossRef PubMed
  20.Gill JJ, Pacan JC, Carson ME, Leslie KE, Griffiths MW, Sabour PM (2006) Efficacy and pharmacokinetics of bacteriophage therapy in treatment of subclinical Staphylococcus aureus mastitis in lactating dairy cattle. Antimicrob Agents Chemother 50(9):2912PubMedCentral CrossRef PubMed
  21.Gopinath SM, Suneetha TB, Mruganka VD, Ananda S (2011) Evaluation of antibacterial activity of Tabernaemontana divaricata (L.) leaves against the causative organisms of bovine mastitis. Int J Res Phytochem Pharmacol 1(4):211–213
  22.Hafez SM, Ismael AB, Mahmoud MB, Elaraby AA (2013) Development of new strategy for non-antibiotic therapy: bovine lactoferrin has a potent antimicrobial and immunomodulator effects. Adv Infect Dis 3:185–192CrossRef
  23.Hoedemaker M, Korff B, Edler B, Emmert M, Bleckmann E (2001) Dynamics of Staphylococcus aureus infections during vaccination with an autogenous bacterin in dairy cattle. J Vet Med 48(5):373–383CrossRef
  24.Kazemi J, Ahmadi M, Saei HD, Adib hesami M (2014) Antibacterial effect of silver nanoparticles along with protein synthesis-inhibiting antibiotics on Staphylococcus aureus isolated from cattle mastitis. Biol J Microorg 2(8):15–22
  25.Khayatnouri MH, Topchi A (2013) Evaluation of antibacterial effect of monolaurin on Staphylococcus aureus isolated from bovine mastitis. Afr J Pharm Pharmacol 7(19):1163–1166
  26.Kutila T, Pyörälä S, Kaartinen L, Isomäki R, Vahtola K, Myllykoski L, Saloniemi H (2003) Lactoferrin and citrate concentrations at drying-off and during early mammary involution of dairy cows. J Vet Med Series A 50(7):350–353CrossRef
  27.Kwiatek M, Parasion S, Mizak L, Gryko R, Bartoszcze M, Kocik J (2012) Characterization of a bacteriophage, isolated from a cow with mastitis, that is lytic against Staphylococcus aureus strains. Arch Virol 157:225–234CrossRef PubMed
  28.Laport MS, Marinho PR, Santos OC, de Almeida P, Romanos MT, Muricy G, Brito MA, Giambiagi-deMarval M (2012) Antimicrobial activity of marine sponges against coagulase-negative staphylococci isolated from bovine mastitis. Vet Microbiol 155(2–4):362–368CrossRef PubMed
  29.Loeza-Ángeles H, López-Meza JE, Ochoa-Zarzosa A (2011) Antimicrobial effects of plant defence peptides expressed by bovine endothelial cells on intracellular pathogens. Electron J Biotechnol 14(5):1–1
  30.Mubarack HM, Doss AR, Dhanabalan R, Venkataswamy R (2011) Activity of some selected medicinal plant extracts against bovine mastitis pathogens. J Anim Vet Adv 10(6):738–741CrossRef
  31.O’Flaherty S, Coffey A, Meaney WJ, Fitzgerald GF, Ross RP (2005) Inhibition of bacteriophage K proliferation on Staphylococcus aureus in raw bovine milk. Lett Appl Microbiol 41:274–279CrossRef PubMed
  32.Ohno T, Kita M, Yamaoka Y, Imamura S, Yamamoto T, Mitsufuji S, Kodama T, Kashima K, Imanishi J (2003) Antimicrobial activity of essential oils against Helicobacter pylori. Helicobacter 8:207–215CrossRef PubMed
  33.Olson ME, Ceri H, Morck DW, Buret AG, Read RR (2002) Biofilm bacteria: formation and comparative susceptibility to antibiotics. Can J Vet Res 66(2):86–92PubMedCentral PubMed
  34.Pereira UP, Oliveira DGS, Mesquita LR, Costa GM, Pereira LJ (2011) Efficacy of Staphylococcus aureus vaccines for bovine mastitis: a systematic review. Vet Microbiol 148:117–124CrossRef PubMed
  35.Petrovski KR, Trajcev M, Buneski G (2006) A review of the factors affecting the costs of bovine mastitis. J South Afr Vet Assoc 77:52–60
  36.Philpot WN, Nickerson SC (1999) Mastitis: counter attack. Westfalia Surge LLC, Illinois
  37.Ruegg PL (2009) Management of mastitis on organic and conventional dairy farms. J Anim Sci 87:43–55CrossRef PubMed
  38.Santana HF, Barbosa AAT, Ferreira SO, Mantovani HC (2012) Bactericidal activity of ethanolic extracts of propolis against Staphylococcus aureus isolated from mastitic cows. World J Microbiol Biotechnol 28(2):485–491CrossRef PubMed
  39.Seegers H, Fourichon C, Beaudeau F (2003) Production effects related to mastitis and mastitis economics in dairy cattle herds. Vet Res 34:475–491CrossRef PubMed
  40.Serna-Cock L, Enríquez-Valencia CE, Jiménez-Obando EM, Campos-Gaona R (2012) Effects of fermentation substrates and conservation methods on the viability and antimicrobial activity of Weissella confusa and its metabolites. Electron J Biotechnol 5(3):6
  41.Shkreta L, Talbot BG, Diarra MS, Lacasse P (2004) Immune responses to a DNA/protein vaccination strategy against Staphylococcus aureus induced mastitis in dairy cows. Vaccine 23:114–126CrossRef PubMed
  42.Taemchuay D, Rukkwamsuk T, Sakpuaram T, Ruangwises N (2009) Antibacterial activity of crude extracts of Centella asiatica against Staphylococcus aureus in bovine mastitis. Kasetsart Vet 19(3):119–128
  43.Talbot BG, Lacasse P (2005) Progress in the development of mastitis vaccines. Livest Prod Sci 98:101–113CrossRef
  44.Tiwari J, Babra C, Tiwari HK, Williams V, De Wet S, Gibson J, Paxman A, Morgan E, Costantino P, Sunagar R, Isloor S, Hegde NR, Mukkur T (2013) Trends in therapeutic and prevention strategies for management of bovine mastitis: an overview. Vaccines Vaccin 4:2
  45.Tolosa T, Wagaye H, Regassa F (2009) A study on in vitro antimicrobial effects of some selected plants on Staphylococcus aureus isolated from bovine clinical mastitis. Int J Vet Med 8(1):1–7
  46.Valde JP, Lawson LG, Lindberg A, Agger JF, Saloniemi H, Østerås O (2004) Cumulative risk of bovine mastitis treatments in Denmark, Finland, Norway and Sweden. Acta Vet Scand 45:201–210PubMedCentral CrossRef PubMed
  47.Xuefeng Y (2009) Post-antibiotic effect of amoxicillin nanoparticles against main pathogenic bacteria of bovine mastitis in vitro. J Northwest Sci-Tech Univ Agric For 37(6):1–6
  48.Wang XF, Zhang SL, Zhu LY, Xie SY, Dong Z, Wang Y, Zhou WZ (2012) Enhancement of antibacterial activity of tilmicosin against Staphylococcus aureus by solid lipid nanoparticles in vitro and in vivo. Vet J 191(1):115–120CrossRef PubMed
  49.White DG, McDermott PF (2001) Emergence and transfer of antibiotic resistance. J Dairy Sci 84(E. Suppl):E151–E155CrossRef
  50.Wilson DJ, González RN (2003) Vaccination strategies for reducing clinical severity of coliform mastitis. Vet Clin North Am Food Anim Pract 19:187–197CrossRef PubMed
  51.Zecconi A, Binda E, Borromeo V, Piccinini R (2005) Relationship between some Staphylococcus aureus pathogenic factors and growth rates and somatic cell counts. J Dairy Res 72:203–208CrossRef PubMed
  
• 作者单位：Fernanda Gomes (1)
  Mariana Henriques (1)
  
  1. LIBRO – Laboratório de Investigação em Biofilmes Rosário Oliveira, CEB, Center of Biological Engineering, University of Minho, Campus de Gualtar, 4710-057, Braga, Portugal
  
• 刊物类别：Biomedical and Life Sciences
• 刊物主题：Life Sciences
  Microbiology
  Biotechnology
  
• 出版者：Springer New York
• ISSN：1432-0991

文摘

Mastitis is defined as the inflammatory response resulting of the infection of the udder tissue and it is reported in numerous species, namely in domestic dairy animals. This pathology is the most frequent disease of dairy cattle and can be potentially fatal. Mastitis is an economically important pathology associated with reduced milk production, changes in milk composition and quality, being considered one of the most costly to dairy industry. Therefore, the majority of research in the field has focused on control of bovine mastitis and many efforts are being made for the development of new and effective anti-mastitis drugs. Antibiotic treatment is an established component of mastitis control programs; however, the continuous search for new therapeutic alternatives, effective in the control and treatment of bovine mastitis, is urgent. This review will provide an overview of some conventional and emerging approaches in the management of bovine mastitis’ infections.